55 related articles for article (PubMed ID: 38636895)
1. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages.
Dong M; Zhang X; Peng P; Chen Z; Zhang Y; Wan L; Xiang W; Liu G; Guo Y; Xiao Q; Wang B; Guo D; Zhu M; Yu X; Wan F
Cancer Lett; 2024 May; 590():216801. PubMed ID: 38479552
[TBL] [Abstract][Full Text] [Related]
2. SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment.
Kaminska P; Ovesen PL; Jakiel M; Obrebski T; Schmidt V; Draminski M; Bilska AG; Bieniek M; Anink J; Paterczyk B; Jensen AMG; Piatek S; Andersen OM; Aronica E; Willnow TE; Kaminska B; Dabrowski MJ; Malik AR
EMBO Rep; 2024 May; 25(5):2278-2305. PubMed ID: 38499808
[TBL] [Abstract][Full Text] [Related]
3. Pericytes Are Immunoregulatory Cells in Glioma Genesis and Progression.
Martinez-Morga M; Garrigos D; Rodriguez-Montero E; Pombero A; Garcia-Lopez R; Martinez S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791110
[TBL] [Abstract][Full Text] [Related]
4. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma.
De Leo A; Ugolini A; Yu X; Scirocchi F; Scocozza D; Peixoto B; Pace A; D'Angelo L; Liu JKC; Etame AB; Rughetti A; Nuti M; Santoro A; Vogelbaum MA; Conejo-Garcia JR; Rodriguez PC; Veglia F
Immunity; 2024 May; 57(5):1105-1123.e8. PubMed ID: 38703775
[TBL] [Abstract][Full Text] [Related]
5. Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.
Wu L; Zhao Z; Shin YJ; Yin Y; Raju A; Vaiyapuri TS; Idzham K; Son M; Lee Y; Sa JK; Chua JYH; Unal B; Zhai Y; Fan W; Huang L; Hu H; Gunaratne J; Nam DH; Jiang T; Tergaonkar V
Nat Cell Biol; 2024 Jun; 26(6):1003-1018. PubMed ID: 38858501
[TBL] [Abstract][Full Text] [Related]
6. Microglia and glioblastoma heterocellular interplay sustains tumour growth and proliferation as an off-target effect of radiotherapy.
Alberghina C; Torrisi F; D'Aprile S; Longhitano L; Giallongo S; Scandura G; Mannino G; Mele S; Sabini MG; Cammarata FP; Russo G; Abdelhameed AS; Zappalà A; Lo Furno D; Giuffrida R; Li Volti G; Tibullo D; Vicario N; Parenti R
Cell Prolif; 2024 Jun; 57(6):e13606. PubMed ID: 38454614
[TBL] [Abstract][Full Text] [Related]
7. Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic Genes.
Mistry AM; Daneshmand J; Seo SJ; Lehman NL; Miller DM; Goodin DA; Frieboes HB; Chen J; Masters A; Williams BJ; Yaddanapudi K
Curr Oncol; 2024 Feb; 31(3):1183-1194. PubMed ID: 38534921
[TBL] [Abstract][Full Text] [Related]
8. Mapping myeloid cell function: Spatial diversity in tumor and neuronal microenvironment.
Villa G; Delev D; Heiland DH
Cancer Cell; 2024 Jun; 42(6):934-936. PubMed ID: 38861929
[TBL] [Abstract][Full Text] [Related]
9. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
Pires-Afonso Y; Niclou SP; Michelucci A
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
[No Abstract] [Full Text] [Related]
10. The relationship between CD204
Kurdi M; Alghamdi B; Butt NS; Baeesa S
Discov Oncol; 2021 Aug; 12(1):28. PubMed ID: 35201470
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth.
Rivera-Ramos A; Cruz-Hernández L; Talaverón R; Sánchez-Montero MT; García-Revilla J; Mulero-Acevedo M; Deierborg T; Venero JL; Sarmiento Soto M
Cancer Lett; 2024 Jun; 591():216879. PubMed ID: 38636895
[TBL] [Abstract][Full Text] [Related]
12. Tumour-associated CD204
Sørensen MD; Kristensen BW
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12772. PubMed ID: 34713474
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression.
Nóbrega AHL; Pimentel RS; Prado AP; Garcia J; Frozza RL; Bernardi A
Curr Cancer Drug Targets; 2024; 24(6):579-594. PubMed ID: 38310461
[TBL] [Abstract][Full Text] [Related]
14. Microglia and macrophages in glioblastoma: landscapes and treatment directions.
Solomou G; Young AMH; Bulstrode HJCJ
Mol Oncol; 2024 May; ():. PubMed ID: 38712663
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
